Literature DB >> 22115645

Prognostic assessment of coronary artery bypass patients with 64-slice computed tomography angiography: anatomical information is incremental to clinical risk prediction.

Gary R Small1, Yeung Yam, Li Chen, Osman Ahmed, Mouaz Al-Mallah, Daniel S Berman, Victor Y Cheng, Kavitha Chinnaiyan, Gilbert Raff, Todd C Villines, Stephan Achenbach, Matthew J Budoff, Filippo Cademartiri, Tracy Q Callister, Hyuk-Jae Chang, Augustin Delago, Allison Dunning, Martin Hadamitzky, Jorg Hausleiter, Philipp Kaufmann, Fay Lin, Erica Maffei, James K Min, Leslee J Shaw, Benjamin J W Chow.   

Abstract

OBJECTIVES: We sought to determine the incremental prognostic value of 64 multi-slice coronary computed tomography angiography (CCTA) in coronary artery bypass graft (CABG) patients.
BACKGROUND: Prognostication in CABG patients can be difficult. Anatomical assessment of native coronary artery disease and graft patency might provide useful information, but the utility of CCTA in the assessment of CABG patients is unknown.
METHODS: Six hundred fifty-seven CABG patients with all-cause mortality follow-up were identified from a multicenter CCTA registry, of 10,628 patients from 5 CCTA centers. Clinical risk was profiled with modified logistic and additive EuroSCOREs (European Systems for Cardiac Operative Risk Evaluations). The CCTA defined coronary anatomy. Patients were classified by unprotected coronary territory (UCT) or a summary of native vessel disease and graft patency: the coronary artery protection score (CAPS).
RESULTS: Forty-four deaths occurred during a mean follow-up of 20 months. Left ventricular ejection fraction, creatinine, age, severity of native vessel disease, UCT, CAPS, and EuroSCOREs were univariate predictors of mortality (p < 0.001). In multivariate analysis with additive EuroSCORE, UCT (p = 0.004) and CAPS were predictive of events (p < 0.001). In comparison with additive EuroSCORE, CAPS score was associated with a 27% net reclassification index.
CONCLUSIONS: Coronary computed tomography angiography provides incremental anatomical data to clinical risk assessment to help determine the prognosis of patients after CABG. The CAPS evaluation with CCTA might help identify those patients at highest risk.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22115645     DOI: 10.1016/j.jacc.2011.08.047

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Prognostic utility of coronary computed tomographic angiography.

Authors:  Yuka Otaki; Daniel S Berman; James K Min
Journal:  Indian Heart J       Date:  2013-04-12

2.  A thoughtful use of CT angiography among patients with prior coronary artery bypass grafts: more lights than shadows?

Authors:  Umberto Barbero; Mario Iannaccone; Cristina Barbero; Fabrizio D'Ascenzo
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

3.  CT vs SPECT: CT is the first-line test for the diagnosis and prognosis of stable coronary artery disease.

Authors:  Ahmed Aljizeeri; Myra S Cocker; Benjamin J W Chow
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

4.  What have we learned from CONFIRM? Prognostic implications from a prospective multicenter international observational cohort study of consecutive patients undergoing coronary computed tomographic angiography.

Authors:  Yuka Otaki; Reza Arsanjani; Heidi Gransar; Victor Y Cheng; Damini Dey; Troy Labounty; Fay Y Lin; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin Delago; Martin Hadamitzky; Joerg Hausleiter; Philipp Kaufmann; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; Ricardo C Cury; Gudrun Feuchtner; Yong-Jin Kim; Jonathon Leipsic; Daniel S Berman; James K Min
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

Review 5.  2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging.

Authors:  Mouaz H Al-Mallah; Timothy M Bateman; Kelley R Branch; Andrew Crean; Eric L Gingold; Randall C Thompson; Sarah E McKenney; Edward J Miller; Venkatesh L Murthy; Koen Nieman; Todd C Villines; Michael V Yester; Andrew J Einstein; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2022-09-02       Impact factor: 3.872

6.  Coronary dominance and prognosis in patients undergoing coronary computed tomographic angiography: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) registry.

Authors:  Catherine Gebhard; Tobias A Fuchs; Julia Stehli; Heidi Gransar; Daniel S Berman; Matthew J Budoff; Stephan Achenbach; Mouaz Al-Mallah; Daniele Andreini; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha M Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin Delago; Millie J Gomez; Martin Hadamitzky; Joerg Hausleiter; Niree Hindoyan; Gudrun Feuchtner; Yong-Jin Kim; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Gianluca Pontone; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison M Dunning; James K Min; Philipp A Kaufmann
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-04       Impact factor: 6.875

7.  A combination of anatomical and functional evaluations improves the prediction of cardiac event in patients with coronary artery bypass.

Authors:  Hideki Kawai; Masayoshi Sarai; Sadako Motoyama; Hajime Ito; Kayoko Takada; Hiroto Harigaya; Hiroshi Takahashi; Shuji Hashimoto; Yasushi Takagi; Motomi Ando; Hirofumi Anno; Junichi Ishii; Toyoaki Murohara; Yukio Ozaki
Journal:  BMJ Open       Date:  2013-11-11       Impact factor: 2.692

8.  Comparison of coronary CT angiography versus functional imaging for CABG patients: A resource utilization analysis.

Authors:  Gary R Small; Fernanda Erthal; Ali Alenazy; Yeung Yam; Michael Edwards; Andrew Crean; Rob S Beanlands; Terrence D Ruddy; Benjamin J W Chow
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.